Generic Drug News and Research

RSS
Generic Drugs are official nonbrand names by which medicines are known. Generic names usually refer to the chemical name of the drug.
Global generic pharmaceuticals market to reach $231.00 billion in 2017 at 9.29% CAGR

Global generic pharmaceuticals market to reach $231.00 billion in 2017 at 9.29% CAGR

Sihuan's Roxatidine passes Chinese SFDA on-site inspection

Sihuan's Roxatidine passes Chinese SFDA on-site inspection

Is access problem preventing generic drug makers' progress?

Is access problem preventing generic drug makers' progress?

First Edition: May 23, 2012

First Edition: May 23, 2012

Prodigy Generics launches injectable irinotecan

Prodigy Generics launches injectable irinotecan

HCCI's report shows facility prices outpaced general inflation for the privately insured under 65

HCCI's report shows facility prices outpaced general inflation for the privately insured under 65

Teva first quarter net revenues increase 25% to $5.1 billion

Teva first quarter net revenues increase 25% to $5.1 billion

PharMerica first quarter net income increases to $5.6 million

PharMerica first quarter net income increases to $5.6 million

Teva, Mylan settle patent infringement litigation for Nuvigil

Teva, Mylan settle patent infringement litigation for Nuvigil

Leahy introduces generic drug label legislation

Leahy introduces generic drug label legislation

First Edition: April 18, 2012

First Edition: April 18, 2012

Supreme Court rules generic drug makers can challenge branded drug companies' wording in patent applications

Supreme Court rules generic drug makers can challenge branded drug companies' wording in patent applications

First Edition: April 18, 2012

First Edition: April 18, 2012

Synthon receives tentative approval for tadalafil tablets

Synthon receives tentative approval for tadalafil tablets

Teva's ANDA for Provigil entitled to 180-day exclusivity

Teva's ANDA for Provigil entitled to 180-day exclusivity

Teva reports successful outcome of three debut financings

Teva reports successful outcome of three debut financings

Teva launches generic Avalide and Avapro Tablets

Teva launches generic Avalide and Avapro Tablets

Teva introduces generic Provigil

Teva introduces generic Provigil

Consumer should be centre of care when offering alternative medicine brands

Consumer should be centre of care when offering alternative medicine brands

Morning after pills difficult for teenagers to procure

Morning after pills difficult for teenagers to procure